机译:用替代伞蛋白化学疗法治疗新诊断的胶质母细胞瘤患者的截止肿瘤体积阈值:多中心队列研究
Kwong Wah Hosp Dept Neurosurg Hong Kong Peoples R China;
Tuen Mun Hosp Dept Neurosurg Hong Kong Peoples R China;
Princess Margaret Hosp Dept Neurosurg Hong Kong Peoples R China;
Kwong Wah Hosp Dept Neurosurg Hong Kong Peoples R China;
Queen Elizabeth Hosp Dept Neurosurg Hong Kong Peoples R China;
Prince Wales Hosp Dept Surg Div Neurosurg Hong Kong Peoples R China;
Pamela Youde Nethersole Eastern Hosp Dept Neurosurg Hong Kong Peoples R China;
Tuen Mun Hosp Dept Neurosurg Hong Kong Peoples R China;
Kwong Wah Hosp Dept Neurosurg Hong Kong Peoples R China;
Prince Wales Hosp Dept Surg Div Neurosurg Hong Kong Peoples R China;
Glioblastoma; Extent of resection; Residual tumor volume; Overall survival; Temozolomide chemo-radiotherapy; Volumetric analysis;
机译:用替代伞蛋白化学疗法治疗新诊断的胶质母细胞瘤患者的截止肿瘤体积阈值:多中心队列研究
机译:一期研究旨在将双硫仑与替莫唑胺联合用于治疗放化疗后新诊断的胶质母细胞瘤
机译:评价新诊断的胶质母细胞瘤患者扩大替莫唑胺辅助化疗后的伴随化学疗法的疗效-回顾性研究
机译:替莫唑胺在体内治疗多形性胶质母细胞瘤:肿瘤反应的4D模拟模型
机译:长春新碱,伊非替康,替莫唑胺和贝伐单抗(VIT-B)逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
机译:替莫唑胺并发替莫唑胺辅助化学放化疗同时治疗新诊断成胶质细胞瘤的患者:韩国一项回顾性多中心观察研究
机译:单独使用ChemoRomide的ChemoRomide用ChemoRadiOurapy进行新诊断的最大切除的胶质母细胞植物的多中心随机分切胶质母细胞植物的研究。日本临床肿瘤学研究JCOG1703(MACS研究)